Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ko

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
JAMA Dermatology|June 26, 2024
Single-Lesion Skin Cancer Risk Stratification Triage PathwayYiqun Chen, Haiwen Gui, Hanqi Yao, et al.
JAMA Dermatology|March 15, 2023
Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo QualityKailas Vodrahalli, Justin Ko, Albert S Chiou, et al.
The British Journal of Dermatology|April 3, 2025
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with BaricitinibArash Mostaghimi, Brittany Craiglow, Brett King, et al.
Advances in Therapy|July 22, 2021
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance ClaimsMaryanne Senna, Justin Ko, Antonella Tosti, et al.
The Journal of Investigative Dermatology|April 6, 2024
Dermatologists' Perspectives and Usage of Large Language Models in Practice: An Exploratory SurveyHaiwen Gui, Shawheen J Rezaei, Daniel Schlessinger, et al.
Dermatology and Therapy|September 14, 2023
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 StudyDiamant Thaçi, Christos Tziotzios, Taisuke Ito, et al.
Journal of the American Academy of Dermatology|June 6, 2021
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled studyBrett King, Justin Ko, Seth Forman, et al.
JAMA Dermatology|August 14, 2024
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical TrialBrett King, Justin Ko, Ohsang Kwon, et al.
Journal of the American Academy of Dermatology|June 9, 2024
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studiesArash Mostaghimi, Justin Ko, Antonella Tosti, et al.
Skin Health and Disease|October 6, 2023
Development of a digital tool for home-based monitoring of skin disease for older adultsSven van Egmond, Zhuo R Cai, Vanessa Nava, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
JAMA Dermatology|June 26, 2024
Single-Lesion Skin Cancer Risk Stratification Triage PathwayYiqun Chen, Haiwen Gui, Hanqi Yao, et al.
JAMA Dermatology|March 15, 2023
Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo QualityKailas Vodrahalli, Justin Ko, Albert S Chiou, et al.
The British Journal of Dermatology|April 3, 2025
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with BaricitinibArash Mostaghimi, Brittany Craiglow, Brett King, et al.
Advances in Therapy|July 22, 2021
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance ClaimsMaryanne Senna, Justin Ko, Antonella Tosti, et al.
The Journal of Investigative Dermatology|April 6, 2024
Dermatologists' Perspectives and Usage of Large Language Models in Practice: An Exploratory SurveyHaiwen Gui, Shawheen J Rezaei, Daniel Schlessinger, et al.
Dermatology and Therapy|September 14, 2023
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 StudyDiamant Thaçi, Christos Tziotzios, Taisuke Ito, et al.
Journal of the American Academy of Dermatology|June 6, 2021
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled studyBrett King, Justin Ko, Seth Forman, et al.
JAMA Dermatology|August 14, 2024
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical TrialBrett King, Justin Ko, Ohsang Kwon, et al.
Journal of the American Academy of Dermatology|June 9, 2024
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studiesArash Mostaghimi, Justin Ko, Antonella Tosti, et al.
Skin Health and Disease|October 6, 2023
Development of a digital tool for home-based monitoring of skin disease for older adultsSven van Egmond, Zhuo R Cai, Vanessa Nava, et al.
Pageof 6